The 1 September 2014 issue of the New Zealand Pharmaceutical Schedule is now available. The new Schedule contains two new listings:

• Azacitidine (Vidaza) - myelodysplastic syndromes
• Lenalidomide (Revlimid) - multiple myeloma

For more details, go to: http://www.pharmac.govt.nz/2014/08/18/SU.pdf